Pharming (PHAR) Return on Equity [ROE] (2021 - 2026)
Pharming (PHAR) recorded Return on Equity [ROE] of -14.80% in Q2 2026, down 1.76 percentage points from -13.04% a year earlier but up 1.04 percentage points from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Pharming reported Return on Equity [ROE] of 1.02%, up 7.70 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -24.08 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -6.68% in FY2024 (-1.70 pp), -4.98% in FY2023 (-19.22 pp), 14.24% in FY2022 (+5.74 pp) and 8.50% in FY2021 (-16.59 pp).
- Quarterly Return on Equity [ROE] has ranged from -17.16% in Q3 2025 to 42.33% in Q3 2022 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has declined for 15 consecutive quarters, with an average year-over-year change of -3.88 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 19.45 percentage points in Q3 2022, against a drop of 53.07 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -15.84% (Q1 2026), -15.97% (Q4 2025) and -17.16% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn | -0.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.47% |
| Mar 31, 2026 | -2.94% |
| Dec 31, 2025 | -6.54% |
| Sep 30, 2025 | -4.69% |
| Jun 30, 2025 | -5.36% |
| Mar 31, 2025 | -8.34% |
| Dec 31, 2024 | -7.67% |
| Sep 30, 2024 | -8.55% |
| Jun 30, 2024 | -7.34% |
| Mar 31, 2024 | -3.07% |
| Dec 31, 2023 | -4.92% |
| Sep 30, 2023 | -10.74% |
| Jun 30, 2023 | -8.21% |
| Mar 31, 2023 | -0.99% |
| Dec 31, 2022 | 13.38% |
| Sep 30, 2022 | 42.23% |
| Jun 30, 2022 | 16.65% |
| Mar 31, 2022 | 23.61% |
| Dec 31, 2021 | 28.83% |
| Sep 30, 2021 | 21.93% |
API Access
Pharming Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();